4//SEC Filing
Zeskind Benjamin J. 4
Accession 0001415889-22-002061
CIK 0001790340other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:19 PM ET
Size
7.6 KB
Accession
0001415889-22-002061
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Exercise/Conversion
Stock Option
2022-02-28−2,000→ 208,000 totalExercise: $3.01Exp: 2029-12-15→ Class A Common Stock (2,000 underlying) - Exercise/Conversion
Class A Common Stock
2022-02-28$3.01/sh+2,000$6,020→ 2,254,352 total
Holdings
- 894,927(indirect: See Foonote)
Class A Common Stock
Footnotes (2)
- [F1]Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.
- [F2]The option has fully vested and is currently exercisable.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001870062
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:19 PM ET
- Size
- 7.6 KB